Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 268

Results For "disease"

2832 News Found

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
Clinical Trials | September 20, 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021


Mylab Discovery Solutions acquires Sanskritech in an all-cash deal
Clinical Trials | September 20, 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021


Samhita and Cipla collaborate to study the role of pharmacists in healthcare
Public Health | September 18, 2021

Samhita and Cipla collaborate to study the role of pharmacists in healthcare

Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients


Union Minister Jitendra Singh launch free telemedicine facility
Public Health | September 18, 2021

Union Minister Jitendra Singh launch free telemedicine facility

Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India


Roche receives positive CHMP opinion for Gavreto
Drug Approval | September 18, 2021

Roche receives positive CHMP opinion for Gavreto

If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC


Apollo Hospital Chennai completes India’s first robotic bariatric surgery
Hospitals | September 18, 2021

Apollo Hospital Chennai completes India’s first robotic bariatric surgery

This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports


Excision receives U.S. FDA clearance for first-in-human CRISPR Phase I/II trail for HIV
Biotech | September 18, 2021

Excision receives U.S. FDA clearance for first-in-human CRISPR Phase I/II trail for HIV

Initiation of EBT-101 Phase 1/2 clinical trial expected later this year


Cosara Diagnostics receives CDSCO licence to manufacture Dengue test kit
Medical Device | September 17, 2021

Cosara Diagnostics receives CDSCO licence to manufacture Dengue test kit

It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.


Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation
Biotech | September 17, 2021

Biocon Biologics to offer Serum Institute of Life Sciences 15 pc stake at US $ 4.9 billion valuation

BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets


Roche set to acquire long-term partner TIB Molbiol
Biotech | September 16, 2021

Roche set to acquire long-term partner TIB Molbiol

The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases